LIGAND PHARMACEUTICALS INC - FORM 10-K - EX-21.1 - SUBSIDIARIES OF REGISTRANT - March 3, 2010

Attached files

file filename
10-K - FORM 10-K - LIGAND PHARMACEUTICALS INCd10k.htm
EX-32.1 - CERTIFICATION OF BY PRINCIPAL EXECUTIVE OFFICER - SECTION 906 - LIGAND PHARMACEUTICALS INCdex321.htm
EX-31.2 - CERTIFICATION OF BY PRINCIPAL FINANCIAL OFFICER - SECTION 302 - LIGAND PHARMACEUTICALS INCdex312.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-GRANT THORNTON LLP - LIGAND PHARMACEUTICALS INCdex231.htm
EX-23.2 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-BDO SEIDMAN, LLP - LIGAND PHARMACEUTICALS INCdex232.htm
EX-32.2 - CERTIFICATION OF BY PRINCIPAL FINANCIAL OFFICER - SECTION 906 - LIGAND PHARMACEUTICALS INCdex322.htm
EX-10.361 - AMENDMENT TO DISCOVERY COLLABORATION AGREEMENT - LIGAND PHARMACEUTICALS INCdex10361.htm
EX-31.1 - CERTIFICATION OF BY PRINCIPAL EXECUTIVE OFFICER - SECTION 302 - LIGAND PHARMACEUTICALS INCdex311.htm

Exhibit 21.1

LIGAND PHARMACEUTICALS INCORPORATED

LIST OF SUBSIDIARIES

 

Name

    Jurisdiction of Incorporation     

Glycomed Incorporated

    California   

Allergan Ligand Retinoid Therapeutics, Inc.

    Delaware   

Ligand Pharmaceuticals International, Inc.

    Delaware   

Ligand JVR, Inc.

    Delaware   

Seragen Incorporated

    Delaware   

Seragen Technology, Inc.

    Delaware   

Pharmacopeia, LLC

    Delaware   

Metabasis Therapeutics, Inc.

    Delaware   

Neurogen Corporation

    Delaware   

Stock widget

Investing forum

LIGAND PHARMACEUTICALS INC Reports